↓ Skip to main content

Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
11 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
11 Mendeley